Affiliation:
1. Myasnikov Institute of Clinical Cardiology, Chyazov National Medical Research Center for Cardiology
Abstract
Hepatobiliary scintigraphy using radiopharmaceuticals (RPh) labeled with short-lived technetium‑99m (99mТс) has been used since the mid‑1970s and still retains its diagnostic value. The lecture focuses on key aspects of the pharmacokinetics of lidocaine analogs based on N-substitutions of iminodiacetic acid. The methodology and diagnostic significance of hepatocholescintigraphy with Bromesida® 99mTс (mebrofenin), including computer registration of RPh passage, anatomical and functional characteristics of liver, bile ducts, gallbladder and duodenum, are considered. Scintigraphic semiotics in choledochal cysts, acute and chronic cholecystitis, gallbladder and duodenum dyskinesia, are discussed. The presented clinical case illustrates the possibilities of Bromesida® 99mTс scintigraphy in the gallbladder form anomaly.
Reference25 articles.
1. Abel JJ, Rowntree LG. On the pharmacological action of same phtaleins and their devaties with espeсial reference to their behavior as purgatives. Int J Pharmac Exp Ther. 1909; 1(2): 231–64.
2. Dalprat G. Studies on liver functions:rose bengal elimination from blood as influenced by liver injury. Arch Int Med. 1923; 32: 401.
3. Taplin GV, Meredith OM, Kade H. The radioactive (I131-tagged-Rose Bengal uptake) excretion test for the liver function using external gamma-ray scintillation counting techniques. J Lab Clin Med. 1955; 45(5): 665–78.
4. Ziessman HA. Hepatobiliary scintigraphy in 2014. J Nucl Med. 2014; 55(6): 967–75. https://doi.org/10.2967/jnumed.113.131490.
5. Loberg MD, Cooper M, Harvey E, et al. Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid. J Nucl Med. 1976; 17(7): 633–8.